GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » IsoPlexis Corp (NAS:ISO) » Definitions » Beneish M-Score

IsoPlexis (IsoPlexis) Beneish M-Score : -8.29 (As of May. 14, 2024)


View and export this data going back to 2021. Start your Free Trial

What is IsoPlexis Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -8.29 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for IsoPlexis's Beneish M-Score or its related term are showing as below:

ISO' s Beneish M-Score Range Over the Past 10 Years
Min: -8.29   Med: -4.69   Max: -1.08
Current: -8.29

During the past 4 years, the highest Beneish M-Score of IsoPlexis was -1.08. The lowest was -8.29. And the median was -4.69.


IsoPlexis Beneish M-Score Historical Data

The historical data trend for IsoPlexis's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IsoPlexis Beneish M-Score Chart

IsoPlexis Annual Data
Trend Dec19 Dec20 Dec21 Dec22
Beneish M-Score
- - -1.08 -8.29

IsoPlexis Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.08 -1.20 -2.14 -1.82 -8.29

Competitive Comparison of IsoPlexis's Beneish M-Score

For the Medical Devices subindustry, IsoPlexis's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IsoPlexis's Beneish M-Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, IsoPlexis's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where IsoPlexis's Beneish M-Score falls into.



IsoPlexis Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of IsoPlexis for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.1306+0.528 * -9.1939+0.404 * 1.5449+0.892 * 0.9712+0.115 * 1.2235
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.165+4.679 * -0.047603-0.327 * 2.5768
=-8.29

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec22) TTM:Last Year (Dec21) TTM:
Total Receivables was $4.50 Mil.
Revenue was 3.361 + 4.484 + 4.005 + 4.911 = $16.76 Mil.
Gross Profit was -7.814 + 2.257 + 2.076 + 2.555 = $-0.93 Mil.
Total Current Assets was $71.87 Mil.
Total Assets was $109.07 Mil.
Property, Plant and Equipment(Net PPE) was $16.31 Mil.
Depreciation, Depletion and Amortization(DDA) was $4.96 Mil.
Selling, General, & Admin. Expense(SGA) was $72.56 Mil.
Total Current Liabilities was $17.71 Mil.
Long-Term Debt & Capital Lease Obligation was $50.09 Mil.
Net Income was -33.212 + -18.455 + -25.606 + -28.725 = $-106.00 Mil.
Non Operating Income was 0.156 + -0.574 + -3.747 + 0.001 = $-4.16 Mil.
Cash Flow from Operations was -15.478 + -16.896 + -32.362 + -31.906 = $-96.64 Mil.
Total Receivables was $4.10 Mil.
Revenue was 5.542 + 4.193 + 4.289 + 3.234 = $17.26 Mil.
Gross Profit was 2.849 + 1.973 + 2.284 + 1.66 = $8.77 Mil.
Total Current Assets was $158.44 Mil.
Total Assets was $187.47 Mil.
Property, Plant and Equipment(Net PPE) was $5.78 Mil.
Depreciation, Depletion and Amortization(DDA) was $2.31 Mil.
Selling, General, & Admin. Expense(SGA) was $64.12 Mil.
Total Current Liabilities was $13.58 Mil.
Long-Term Debt & Capital Lease Obligation was $31.65 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(4.502 / 16.761) / (4.1 / 17.258)
=0.2686 / 0.237571
=1.1306

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(8.766 / 17.258) / (-0.926 / 16.761)
=0.507938 / -0.055247
=-9.1939

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (71.865 + 16.305) / 109.068) / (1 - (158.443 + 5.778) / 187.472)
=0.191605 / 0.124024
=1.5449

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=16.761 / 17.258
=0.9712

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(2.307 / (2.307 + 5.778)) / (4.959 / (4.959 + 16.305))
=0.285343 / 0.233211
=1.2235

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(72.555 / 16.761) / (64.123 / 17.258)
=4.328799 / 3.715552
=1.165

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((50.09 + 17.711) / 109.068) / ((31.646 + 13.581) / 187.472)
=0.62164 / 0.241247
=2.5768

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-105.998 - -4.164 - -96.642) / 109.068
=-0.047603

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

IsoPlexis has a M-score of -8.29 suggests that the company is unlikely to be a manipulator.


IsoPlexis Beneish M-Score Related Terms

Thank you for viewing the detailed overview of IsoPlexis's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


IsoPlexis (IsoPlexis) Business Description

Traded in Other Exchanges
N/A
Address
35 North East Industrial Road, Branford, CT, USA, 06405
IsoPlexis Corp is a developer of a single-cell detection system designed to accelerate insights in the field of cancer. It designed a platform to reveal functional protein biology and cellular signaling networks at single-cell resolution to accelerate the development of advanced medicines.
Executives
Nachum Shamir director 12212 TECHNOLOGY BLVD, AUSTIN TX 78727
John Strahley officer: Chief Financial Officer 35 NORTH EAST INDUSTRIAL ROAD, BRANFORD CT 06405
Sean Mackay director, officer: Chief Executive Officer 35 NORTH EAST INDUSTRIAL ROAD, BRANFORD CT 06405
Rew Richard W. Ii officer: SVP, GC & Secretary 7000 WEST WILLIAM CANNON, BUILDING ONE, AUSTIN TX 78735
James R Heath director C/O ISOPLEXIS, 35 NE INDUSTRIAL RD, BRANFORD CT 06405
Michael Egholm director 1 FRANKLIN STREET, UNIT 3104, BOSTON MA 02110
Siddhartha Kadia director 7475 LUSK BOULEVARD, SAN DIEGO CA 92121
Jason W. Myers director C/O ARCHERDX, INC., 2477 55TH STREET, SUITE 202, BOULDER CO 80301
John G. Conley director 396 GREAT MEADOWS RD, CONCORD MA 01742-1803
Gregory P. Ho director, 10 percent owner C/O SPRING MOUNTAIN CAPITAL, LP, 650 MADISON AVENUE, 20TH FLOOR, NEW YORK NY 10022
Peter Siesel officer: Chief Commercial Officer 35 NORTH EAST INDUSTRIAL ROAD, BRANFORD CT 06405
Jing Zhou officer: Chief Scientific Officer 35 NORTH EAST INDUSTRIAL ROAD, BRANFORD CT 06405
Rajesh T. Khakhar officer: VP, Finance 35 NORTH INDUSTRIAL ROAD, BRANFORD CT 06405
Northpond Capital Gp, Llc 10 percent owner 4 BRATTLE STREET, FLOOR 3, CAMBRIDGE MA 02138
Perceptive Life Sciences Master Fund Ltd 10 percent owner C/O PERCEPTIVE ADVISORS LLC, 51 ASTOR PLACE, 10TH FLOOR, NEW YORK NY 10003